Wellness-based development would be first of kind here
Satori Pointe is being marketed as a campus where medical offices, fitness-oriented retailers and residents would co-exist.
Health Care & Life Sciences
Articles
Dow Agro boosts sales, profit in second quarter
Indianapolis-based Dow AgroSciences improved sales and profit in its second quarter thanks to higher volumes and lower costs,
the company said Tuesday morning.
WellPoint, peers focus on health reform rules, campaign
WellPoint Inc., UnitedHealth Group Inc. and three other health insurers, criticized by Democrats during the health care reform
debate, are seeking to influence how the new law will be implemented, and possibly change it, by campaigning for supportive
congressional candidates.
Senator asks Zimmer for info about product complaints
Inquiry stemmed from an article in the New York Times about a dispute between the Warsaw-based maker of artificial hip and knee joints and two of its consultants.
Lilly among bidders for Denmark company, source says
Copenhagen-based health-care company Ascendis Pharma A/S received offers of about $400 million, an unidentified source said.
Ascendis may choose a final bidder by early September.
New law takes American Health Network full circle
Dr. Ben Park joined Anthem Blue Cross and Blue Shield in 1993 to start a large group of primary care physicians who would
institute a concept called managed care. Now American Health Network is
well-positioned to take advantage of the new version of managed care, called accountable care.
Ex-Dow AgroSciences employee accused of stealing trade secrets
The U.S. Department of Justice has charged Ke-xue Huang, a native of China’s Hunan province, of stealing trade secrets of
a Dow AgroSciences insecticide and giving them to the People’s Republic of China. Federal agents arrested the former Dow Agro
scientist July 13 in Westboro, Mass.
Indiana life sciences companies capture more venture capital money in first half of 2010
Venture dollars for Hoosier companies are still few, but the flow of deals is picking up.
Hill-Rom raises profit forecast after quarterly earnings jump
The Batesville-based maker of hospital beds and furniture announced Wednesday night that it earned $30.6 million in its third quarter, up from $20.2 million in the same quarter of 2009.
Investors fear insurers’ rosy outlook will boost regulators’ scrutiny
Indianapolis-based WellPoint Inc. became the third U.S. health insurer this month to increase its 2010 profit forecast, stirring
investor concern that state and federal regulators may increase scrutiny of industry pricing.
Lilly loses appeal over patent for cancer drug Gemzar
A U.S. appeals court Wednesday said a lower court was correct to invalidate a patent on the medicine that expires in 2013.
Gemzar generated $1.36 billion in global sales in 2009.
WellPoint gains confidence as profits rise
The Indianapolis-based health insurer raised its full-year profit forecast after it earned $722.4 million, 4 percent higher
than during the same quarter a year ago. Revenue and health plan membership fell.
Exchanges sprout around the country
When the Indiana Health Information Exchange launched in 2004, it was one of nine truly operational exchanges around the country.
Today, the Indianapolis-based organization is one of 73, according to the latest national survey by the eHealth Initiative.
Life sciences deals pick up momentum
Venture dollars for Indiana life sciences companies are still few, but the flow of deals is picking up. Nine Hoosier companies
scored investments totaling $10.4 million during the first six months of the year.
Survey: Many hospital patients in dark about debt-relief options
Marion County survey finds 80 percent of respondents in debt to local hospitals, with about half saying they were never informed
about the availability
of charity care or payment plans.
Local investors make big bet on senior housing
With the first baby boomers set to turn 65 in six months, investments in senior housing are heating up. A group of Indianapolis-area
professionals—including Mark Waterfill (left) and Tony Schantz—have banded together to launch three senior housing
projects around the state, spending $49 million and looking
to do more.
UPDATE: Patent expirations overshadow Lilly profits
Investors are focused on whether Eli Lilly and Co. can continue dividend payments when patent expirations hit in the new few
years and whether the company's drug development pipeline can replace lost revenue.
Lilly’s second-quarter profits surge 16 percent
Indianapolis-based drugmaker Eli Lilly and Co. recorded profits of $1.3 billion, or $1.22 per share, during the three months
ended June 30,
even after paying $27 million in severance to laid off employees.
Lilly completes $180 million acquisition of Alnara
Massachusetts-based Alnara Pharmaceuticals Inc. is a privately held company
developing an enzyme-replacement therapy for disorders of the pancreas.
New rules raise stakes for Lilly drug
Drugmakers testing experimental Alzheimer’s medicines—including Eli Lilly and Co.—got good news last week
when the National Institute on Aging and the Alzheimer’s Association proposed new guidelines to make earlier diagnoses
of the disease.